Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Licensing and Collaboration Opportunities

Licensing and Collaboration Opportunities

                        FDA Technologies Available for Licensing and Collaboration
          Recently Issued U.S. Patents to FDA
          The FDA Licensing Process
          Types of Licenses Home
          Science & Research
          FDA Technology Transfer Program
          Licensing and Collaboration Opportunities
          Types of LicensesLicensing and Collaboration Opportunities Types of Licenses
  
  	
    Share
    Post
    Linkedin

    Email
    PrintFDA is looking for commercial partners who are interested in developing and marketing technologies created by FDA scientists.FDA offers several types license agreements: **Internal Commercial Use Licenses**-- grants a licensee the nonexclusive right to make and use the invention for internal use only. These licenses do not grant the right to sell or otherwise distribute the invention, but allow the licensee to use the invention in their commercial development activities.**Biological Materials License (BML) --**allows a Company to license biological materials FDA has developed for which patent protection cannot or will not be obtained. This type of license typically is nonexclusive and facilitates the commercial development of biological materials developed in FDA laboratories. FDA has two kinds of BMLs:Biological Materials License used for field limited commercial purposesBiological Materials License--Internal research purposes only. The licensee may not distribute the invention, but may use the invention in their commercial development activities.**Commercial Evaluation Licenses**- grants the nonexclusive right to make and use the technology for the purpose of evaluating its commercial potential. The license is for a limited number of months and does not grant the right to sell or otherwise distribute the technology. Companies are required to obtain a commercial license for further use and/or development of the invention.**Nonexclusive Patent Licenses**- allows a company to commercialize a patented or patent pending technology. Non-exclusive licensing allows use by multiple licensees.FDA has two kinds of non-exclusive patent licenses.Non-Exclusive-patent licenseNon-Exclusive-patent license for internal research purposes only. The licensee may not distribute the technology, but may use the technology in their commercial development activities.**Exclusive Patent Licenses**- allows a company to commercialize a patented, or patent pending, invention. An exclusive license limits the use of the Invention to a single group or entity.FDA uses certain criteria when evaluating an exclusive license application that are based on the requirements set forth in 37 CFR §404.7.These criteria include whether:1. Exclusive licensing serves the best interests of the public 2. Practical application of the invention is not likely to be achieved under a nonexclusive license 3. An exclusive or partially exclusive license is a reasonable and necessary incentive to promote the investment of risk capital to bring the invention to practical application4. Exclusive license terms and conditions are not broader than necessary and5. Exclusive licensing will not lessen competition.

                                                                                  Content current as of:
      02/26/2018Licensing and Collaboration Opportunities

          
                        FDA Technologies Available for Licensing and Collaboration
          Recently Issued U.S. Patents to FDA
          The FDA Licensing Process
          Types of Licenses
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop